A Systematized Scoping Review on the Effect of Oncoplastic Surgery on arm Lymphedema Oncoplast lymphedema
Abstract
Background: With 2.3 million new breast cancer cases globally in 2020 and advances in treatment, the focus has shifted to managing long-term complications such as arm lymphedema. While oncoplastic breast surgery is increasingly used to enhance cosmetic outcomes, its effect on arm lymphedema remains unclear. However, the manipulation of breast tissue and increased vascular and lymphatic disruption raise concerns regarding an elevated risk of postoperative lymphedema. This scoping review explores the existing literature on oncoplastic breast surgery and arm lymphedema.
Methods: This review is part of a systematic review registered in PROSPERO, focusing on lymphedema outcomes. The systematic search identified 4,185 publications, with four studies meeting the inclusion criteria for oncoplastic surgery and arm lymphedema. Transforming to a scoping review, an extra study was included, totaling five studies. Data were extracted on study design, population, type of surgery, lymphedema measurement, and risk factors. Citations and screening were managed using Covidence.
Results: The five studies included 1,532 patients with follow-up periods ranging from 12 months to 7.4 years. Lymphedema rates for OBCS varied between 0% and 11%, with an overall rate of 6.7%.
Conclusion: Due to inconsistent reporting and a lack of long-term follow-up data, no definitive conclusions regarding the risk of arm lymphedema related to oncoplastic breast surgery could be drawn. Future prospective studies with standardized lymphedema measurements and specific evaluations of oncoplastic breast surgery techniques are needed. Addressing these gaps is crucial for improving patient outcomes and guiding clinical decisions.
Full text article
References
Cancer Today - The International Agency for Research on Cancer, https://gco.iarc.who.int/today/files/803/pie.html (accessed 13th of February 2024).
Larønningen S AG, Bray F, Dahl-Olsen ED, Engholm G, Ervik M, Guðmundsdóttir EM, Gulbrandsen J, Hansen HL, Hansen HM, Johannesen TB, Kristensen S, Kristiansen MF, Kønig SM, Lam F, Laversanne M, Lydersen LN, Malila N, Mangrud OM, Miettinen J, Pejicic S, Petterson D, Skog A, Steig BÁ, Tian H, Aagnes B, Storm HH. https://nordcan.iarc.fr/ (accessed 9th of october 2024).
Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 2022; 66: 15-23. 20220902. DOI: 10.1016/j.breast.2022.08.010.
Storm HH, Engholm G, Hakulinen T, et al. Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results. Acta Oncologica 2010; 49: 532-544. DOI: 10.3109/02841861003801148.
Levangie PK and Drouin J. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat 2009; 116: 1-15. 20081125. DOI: 10.1007/s10549-008-0246-4.
Carr HM, Patel RA, Beederman MR, et al. Risk Factors for Upper Extremity Impairment after Mastectomy: A Single Institution Retrospective Review. Plast Reconstr Surg Glob Open 2024; 12: e5684. 20240724. DOI: 10.1097/gox.0000000000005684.
Shen A, Lu Q, Fu X, et al. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies. Support Care Cancer 2022; 31: 18. DOI: 10.1007/s00520-022-07508-2.
Penha TR, Botter B, Heuts EM, et al. Quality of Life in Patients with Breast Cancer-Related Lymphedema and Reconstructive Breast Surgery. J Reconstr Microsurg 2016; 32: 484-490. 20160226. DOI: 10.1055/s-0036-1572538.
Leysen L, Beckwée D, Nijs J, et al. Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis. Support Care Cancer 2017; 25: 3607-3643. DOI: 10.1007/s00520-017-3824-3.
Kibar S, Dalyan Aras M and Ünsal Delialioğlu S. The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Cancer Care (Engl) 2017; 26. DOI: 10.1111/ecc.12433.
Soltanipur M, Yarmohammadi H, Abbasvandi F, et al. Sleep quality and risk of obstructive sleep apnea among breast cancer survivors with and without lymphedema. Sleep and Breathing 2024; 29: 41. DOI: 10.1007/s11325-024-03223-w.
Soltanipur M, Yarmohammadi H, Shahshenas S, et al. The Relationship Between Upper-Limb Lymphedema and Fatigue Among Breast Cancer Survivors. European Journal of Cancer Care 2024; 2024: 3452139. DOI: https://doi.org/10.1155/ecc/3452139.
Christiansen P, Mele M, Bodilsen A, et al. Breast-Conserving Surgery or Mastectomy?: Impact on Survival. Ann Surg Open 2022; 3: e205. 20221005. DOI: 10.1097/AS9.0000000000000205.
Yang X, Lin Q and Wang Q. The impact of breast-conserving surgery and modified radical mastectomy on postoperative wound complications in patients with early breast cancer. International Wound Journal 2024; 21: e14685. DOI: https://doi.org/10.1111/iwj.14685.
Clough KB, Benyahi D, Nos C, et al. Oncoplastic surgery: pushing the limits of breast-conserving surgery. Breast J 2015; 21: 140-146. 20150212. DOI: 10.1111/tbj.12372.
de Oliveira-Junior I, da Costa Vieira RA, Biller G, et al. Factors associated with unsatisfactory cosmetic results in oncoplastic surgery. Front Oncol 2023; 13: 1071127. 20230724. DOI: 10.3389/fonc.2023.1071127.
Chatterjee A, Gass J, Patel K, et al. A Consensus Definition and Classification System of Oncoplastic Surgery Developed by the American Society of Breast Surgeons. Ann Surg Oncol 2019; 26: 3436-3444. 20190411. DOI: 10.1245/s10434-019-07345-4.
Tian R, Zheng Y, Liu R, et al. Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis. The Breast 2024; 77: 103784. DOI: https://doi.org/10.1016/j.breast.2024.103784.
Oberhauser I, Zeindler J, Ritter M, et al. Impact of Oncoplastic Breast Surgery on Rate of Complications, Time to Adjuvant Treatment, and Risk of Recurrence. Breast Care (Basel) 2021; 16: 452-460. DOI: 10.1159/000511728.
Lautrup MD, Rindom MB and Hauerslev KR. Shoulder function following oncoplastic breast conserving surgery—a narrative review. Gland Surgery 2024; 13: 713-721. DOI: doi: 10.21037/gs-23-530.
Lee KT, Kim J, Jeon BJ, et al. Association of the breast reconstruction modality with the development of postmastectomy lymphedema: A long-term follow-up study. Eur J Surg Oncol 2023; 49: 1177-1183. DOI: 10.1016/j.ejso.2023.01.027.
Jammallo LS, Miller CL, Horick NK, et al. Factors associated with fear of lymphedema after treatment for breast cancer. Oncol Nurs Forum 2014; 41: 473-483. DOI: 10.1188/14.ONF.473-483.
Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003; 73: 712-716. DOI: 10.1046/j.1445-2197.2003.02748.x.
Gowda AU, Nie J, Mets E, et al. Risk Factors for Lymphedema After Breast Conservation Therapy and Oncoplastic Reduction. Ann Plast Surg 2021; 87: 248-252. DOI: 10.1097/SAP.0000000000002630.
Brandini da Silva FC, José da Silva J, Sarri AJ, et al. Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version. Clinical Breast Cancer 2019; 19: e85-e100. DOI: https://doi.org/10.1016/j.clbc.2018.10.004.
Lauritzen E, Bredgaard R, Laustsen-Kiel CM, et al. Indocyanine green angiography in oncoplastic breast surgery, a prospective study. J Plast Reconstr Aesthet Surg 2023; 85: 276-286. 20230717. DOI: 10.1016/j.bjps.2023.07.022.
Obi E, Tom MC, Manyam BV, et al. Outcomes with intraoperative radiation therapy for early-stage breast cancer. The Breast Journal 2020; 26: 454-457. DOI: https://doi.org/10.1111/tbj.13574.
Executive Committee of the International Society of L. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53: 3-19.
Ogata F, Fujiu K, Matsumoto S, et al. Excess Lymphangiogenesis Cooperatively Induced by Macrophages and CD4+ T Cells Drives the Pathogenesis of Lymphedema. Journal of Investigative Dermatology 2016; 136: 706-714. DOI: 10.1016/j.jid.2015.12.001.
Ghanta S, Cuzzone DA, Torrisi JS, et al. Regulation of inflammation and fibrosis by macrophages in lymphedema. American Journal of Physiology-Heart and Circulatory Physiology 2015; 308: H1065-H1077. DOI: 10.1152/ajpheart.00598.2014.
Rama S, Atisha D, Evangelista M, et al. The Effect of Oncoplastic Reduction on The Incidence of Post-Operative Lymphedema in Breast Cancer Patients Undergoing Lumpectomy. International Journal of Radiation Oncology, Biology, Physics 2020; 108: e45. DOI: 10.1016/j.ijrobp.2020.07.1085.
Abouelazayem M, Elkorety M and Monib S. Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review. Clinical Breast Cancer 2021; 21: 156-161. DOI: https://doi.org/10.1016/j.clbc.2020.11.017.
Yarmohammadi H, Soltanipur M, Shahrabi Farahani M, et al. Financial burden of lymphedema among breast cancer survivors in Iran: A qualitative study. J Med Vasc 2024; 49: 203-210. 20240919. DOI: 10.1016/j.jdmv.2024.09.001.
Rafn BS, Bodilsen A, von Heymann A, et al. Examining the efficacy of treatments for arm lymphedema in breast cancer survivors: an overview of systematic reviews with meta-analyses. EClinicalMedicine 2024; 67: 102397. 20231222. DOI: 10.1016/j.eclinm.2023.102397.
Nuwayhid R, Langer S and von Dercks N. [Cost comparison of conservative vs. surgical treatment of chronic lymphedema]. Chirurgie (Heidelb) 2025; 96: 41-47. 20240628. DOI: 10.1007/s00104-024-02123-9.
Lilja C, Madsen CB, Damsgaard TE, et al. Surgical treatment algorithm for breast cancer lymphedema-a systematic review. Gland Surg 2024; 13: 722-748. 20240527. DOI: 10.21037/gs-23-503.
Drobot D and Zeltzer AA. Surgical treatment of breast cancer related lymphedema-the combined approach: a literature review. Gland Surg 2023; 12: 1746-1759. 20231222. DOI: 10.21037/gs-23-247.
Authors
Copyright (c) 2025 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.